4-71752606-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000583.4(GC):c.1307C>A(p.Thr436Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.273 in 1,612,616 control chromosomes in the GnomAD database, including 62,145 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.22 ( 4369 hom., cov: 32)
Exomes 𝑓: 0.28 ( 57776 hom. )
Consequence
GC
NM_000583.4 missense
NM_000583.4 missense
Scores
17
Clinical Significance
Conservation
PhyloP100: -0.459
Genes affected
GC (HGNC:4187): (GC vitamin D binding protein) The protein encoded by this gene belongs to the albumin gene family. It is a multifunctional protein found in plasma, ascitic fluid, cerebrospinal fluid and on the surface of many cell types. It binds to vitamin D and its plasma metabolites and transports them to target tissues. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.004927546).
BP6
Variant 4-71752606-G-T is Benign according to our data. Variant chr4-71752606-G-T is described in ClinVar as [Benign]. Clinvar id is 15986.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.284 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GC | NM_000583.4 | c.1307C>A | p.Thr436Lys | missense_variant | 11/13 | ENST00000273951.13 | |
GC | NM_001204307.1 | c.1364C>A | p.Thr455Lys | missense_variant | 12/14 | ||
GC | NM_001204306.1 | c.1307C>A | p.Thr436Lys | missense_variant | 12/14 | ||
GC | XM_006714177.3 | c.1262+1805C>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GC | ENST00000273951.13 | c.1307C>A | p.Thr436Lys | missense_variant | 11/13 | 1 | NM_000583.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.223 AC: 33938AN: 152010Hom.: 4364 Cov.: 32
GnomAD3 genomes
AF:
AC:
33938
AN:
152010
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.253 AC: 63579AN: 251214Hom.: 8454 AF XY: 0.260 AC XY: 35363AN XY: 135780
GnomAD3 exomes
AF:
AC:
63579
AN:
251214
Hom.:
AF XY:
AC XY:
35363
AN XY:
135780
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.278 AC: 406250AN: 1460488Hom.: 57776 Cov.: 36 AF XY: 0.279 AC XY: 203015AN XY: 726636
GnomAD4 exome
AF:
AC:
406250
AN:
1460488
Hom.:
Cov.:
36
AF XY:
AC XY:
203015
AN XY:
726636
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.223 AC: 33964AN: 152128Hom.: 4369 Cov.: 32 AF XY: 0.219 AC XY: 16279AN XY: 74366
GnomAD4 genome
AF:
AC:
33964
AN:
152128
Hom.:
Cov.:
32
AF XY:
AC XY:
16279
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1082
ALSPAC
AF:
AC:
1110
ESP6500AA
AF:
AC:
467
ESP6500EA
AF:
AC:
2489
ExAC
AF:
AC:
30677
Asia WGS
AF:
AC:
811
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
GC1/GC2 POLYMORPHISM Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Jun 01, 1992 | - - |
Levothyroxine response Other:1
other, no assertion criteria provided | research | Pharmacogenomics/Precision medicine lab, University of Petra | - | - The snp had no effect on levothyroxine dosage requirement nor thyroid hormone levels in our study |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
P;P;P
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
0.0090
.;.;B
Vest4
MPC
0.060
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at